M&A Deal Summary

Novartis Acquires Mariana Oncology

On May 2, 2024, Novartis acquired healthcare services company Mariana Oncology for 1.0B USD

Acquisition Highlights
  • This is Novartis’ 2nd transaction in the Healthcare Services sector.
  • This is Novartis’ 9th largest (disclosed) transaction.
  • This is Novartis’ 24th transaction in the United States.
  • This is Novartis’ 6th transaction in Massachusetts.

M&A Deal Summary
Date 2024-05-02
Target Mariana Oncology
Sector Healthcare Services
Buyer(s) Novartis
Deal Type Add-on Acquisition
Deal Value 1.0B USD
Advisor(s) Centerview Partners (Financial)
Goodwin Procter (Legal)

Target

Mariana Oncology

Watertown, Massachusetts, United States
Mariana Oncology is a fully integrated, radiopharmaceutical company pioneering a new standard of care in cancer treatment targeted peptide-based radioligand therapeutics (RLTs) designed to maximize tumor penetration while minimizing toxicity. Mariana Oncology is based in Watertown, Massachusetts.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Novartis

Basel, Switzerland
Category Company
Founded 1996
Sector Life Science
Employees104,323
Revenue 46.7B USD (2023)
DESCRIPTION
Novartis' corporate campus in Basel, Switzerland.
Novartis' corporate campus in Basel, Switzerland.

Novartis is a global healthcare and pharmaceutical enterprise dedicated to advancing medical innovation and enhancing patient well-being. Renowned for its pioneering research and development efforts, Novartis has a comprehensive portfolio encompassing groundbreaking pharmaceuticals, generic medications, biosimilars, and eye care solutions. Novartis was founded in 1996 and is based in Basel, Switzerland.

DEAL STATS #
Overall 32 of 32
Sector (Healthcare Services) 2 of 2
Type (Add-on Acquisition) 28 of 28
State (Massachusetts) 6 of 6
Country (United States) 24 of 24
Year (2024) 3 of 3
Size (of disclosed) 9 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-02-05 MorphoSys

Planegg, Germany

MorphoSys is a global biopharmaceutical company developing innovative medicines in oncology. MorphoSys was formed in 1992 and is based in Planegg, Germany.

Buy €2.7B
Mergr

Product

Company

Legal